智通财经APP获悉，生物技术公司Magnet Biomedicine周五宣布，已与 礼来 (LLY.US)达成一项价值高达12.5亿美元的许可协议，双方将利用Magnet的TrueGlue发现平台共同开发癌症药物。

2025年2月28日——全球知名制药企业礼来公司（Eli Lilly and Company）近日宣布与Magnet ...

Magnet Biomedicine今日宣布与礼来（Eli Lillyand ...

In Unreliable: Bias, Fraud, and the Reproducibility Crisis in Biomedical Research, published next week by Columbia University ...

3月7日上午，Translational Exercise Biomedicine 期刊主编，广州体育学院党委副书记、校长胡敏一行来访上海交通大学期刊中心，广州体育学院党委委员、副校长侯晓晖，广州体育学院期刊中心主任夏江涛陪同调研。上海交通大学期刊中心主任谈毅、副主任蔡云泽，上海交通大学转化医学研究院副研究员王秀强，上海交通大学期刊中心主任助理潘飞出席交流会，会议由谈毅主持。

A team of scientists in the lab of Nobel Prize winner David Baker has created a method for designing proteins that can bind and sense a range of small molecules, with wide applications for biomedicine ...

Scientific literature has increased at a rate of 8-9% annually since 1980, doubling every decade and creating an information ...

Magnet Biomedicine, a leading biopharmaceutical company advancing molecular glue discovery with rational selection and design ...

Magnet Biomedicine has entered a partnership and licence agreement with Eli Lilly to discover, develop and commercialise ...

Researchers have introduced genetic material into plants via their roots, opening a potential pathway for rapid crop improvement. University of Queensland researchers have for the first time ...

Inventiva (IVA) announced the publication in Biomedicine & Pharmacotherapy, a peer-reviewed, scientific journal, of the results from a ...